About 1,998 results

ALLMedicine™ Cluster Headache Center

Research & Reviews  548 results

Secondary cluster headache and numb chin syndrome as initial manifestation of high-grad...
Journal of Medical Case Reports; Munoz-Cerón J, Díaz-Forero F et. al.

Sep 15th, 2021 - Cluster headache is a primary condition characterized by severe headache accompanied by trigeminal autonomic signs. By definition, it is not attributed to underlying etiologies; however, under certain clinical characteristics, secondary etiologies...

Safety pharmacology of acute LSD administration in healthy subjects.
https://doi.org/10.1007/s00213-021-05978-6 10.1111/acps.13249 10.1177/0269881116678781 10.1016/j.paid.2017.06.004 10.1111/j.1360-0443.2006.01423.x 10.1038/s41386-019-0402-z 10.1016/j.biopsych.2019.05.019 10.1177/0269881116662634 10.1007/s00213-017-4769-4 10.1073/pnas.1518377113 10.1055/s-2007-979351 10.1093/ijnp/pyv072 10.1038/npp.2016.82 10.1007/s40262-017-0513-9 10.1007/s00213-019-05417-7 10.1097/NMD.0000000000000113 10.1177/0269881114555249 10.1177/0269881116675513 10.1017/S1481803500012598 10.1007/7854_2016_457 10.1177/0960327110370984 10.1177/0269881116677852 10.1016/0140-6736(92)91469-O 10.1124/jpet.300.1.236 10.1177/0269881121992676 10.1111/bcp.13918 10.1002/cpt.2057 10.1038/s41386-020-00883-6 10.1038/s41386-019-0569-3 10.1016/j.euroneuro.2020.10.002 10.1124/jpet.111.188425 10.1016/S0924-977X(10)70296-0 10.1371/journal.pone.0036476 10.1093/scan/nst161 10.1177/0269881108093587 10.4161/23328940.2014.955433 10.1007/s00213-016-4453-0 10.3390/brainsci8030047 10.1124/pr.115.011478 10.1111/j.1755-5949.2008.00059.x 10.3389/fphar.2017.00974 10.1177/0269881116675512 10.1016/j.biopsych.2014.11.015 10.1177/0269881120959604 10.1007/s00213-017-4733-3 10.1002/dta.2042 10.1177/0269881117691569 10.1038/s41598-021-90343-y 10.1007/s00213-018-5119-x
Psychopharmacology Holze F, Caluori TV et. al.

Sep 14th, 2021 - Lysergic acid diethylamide (LSD) is used in psychiatric and psychological research and investigated as a potential treatment for medical and psychiatric disorders, including depression, anxiety, and cluster headache. Safety data on clinical safety...

tVNS in the management of headache and pain.
Autonomic Neuroscience : Basic & Clinical; Straube A, Eren O

Sep 10th, 2021 - First clinical observations of the therapeutic effect of vagus nerve stimulation were of patients who were treated for refractory epilepsy with a fully implanted vagus nerve stimulator, who also reported an improvement of their migraine and cluste...

Aura in trigeminal autonomic cephalalgia is probably mediated by comorbid migraine with...
Cephalalgia : an International Journal of Headache; Peng KP, Schellong M et. al.

Aug 20th, 2021 - The presence of aura is rare in cluster headache, and even rarer in other trigeminal autonomic cephalalgias. We hypothesized that the presence of aura in patients with trigeminal autonomic cephalalgias is frequently an epiphenomenon and mediated b...

Pediatric-onset trigeminal autonomic cephalalgias: A systematic review and meta-analysis.
Cephalalgia : an International Journal of Headache; Ghosh A, Silva E et. al.

Aug 20th, 2021 - There are five headache disorders composing the trigeminal autonomic cephalalgias (cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), short-lasting unila...

see more →

Drugs  154 results see all →

News  97 results

Cluster Headache Ranked More Painful Than Childbirth

Feb 12th, 2021 - Patients with cluster headache face a double whammy: Physicians too often fail to recognize it, and their condition is among the most severe and debilitating among headache types. In fact, a new survey of patients with cluster headache shows that ...

'Clear Evidence' Oral Steroid Effective for 'Suicide Headache'

Dec 1st, 2020 - Adjunctive oral prednisone appears to significantly reduce cluster headache attacks, new research shows. Results of the multicenter, randomized, double-blind trial show that patients who received the steroid had 25% fewer attacks in the first week...

CGRPs Promising for Prevention of Chronic Cluster Headache

Sep 21st, 2020 - Treatment with calcitonin gene-related peptide (CGRP) monoclonal antibodies may reduce the frequency of chronic cluster headache (CCH) attacks in patients with an inadequate response to other preventive medications, new research shows. In findings...

CGRPs Promising for Prevention of Chronic Cluster Headache

Sep 21st, 2020 - Treatment with calcitonin gene-related peptide (CGRP) monoclonal antibodies may reduce the frequency of chronic cluster headache (CCH) attacks in patients with an inadequate response to other preventive medications, new research shows. In findings...

Consistent Effects for Galcanezumab in Cluster Headache

Jun 24th, 2020 - Galcanezumab (Emgality, Eli Lilly and Co), the humanized monoclonal antibody that targets calcitonin gene–related peptide (CGRP), provides consistent improvements over time for patients with episodic cluster headache, new research suggests. A post...

see more →